RTW Biotech Opportunities Ltd RTWFF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | 0.00% | 83.02% | |||
| Total Revenue | 0.00% | 83.02% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | 83.02% | |||
| SG&A Expenses | 0.00% | 15.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 11.97% | |||
| Operating Income | 0.00% | 151.17% | |||
| Income Before Tax | 0.00% | -40.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -40.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -40.82% | |||
| EBIT | 0.00% | 151.17% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | -40.09% | |||
| Normalized Basic EPS | 0.00% | -90.33% | |||
| EPS Diluted | 0.00% | -40.09% | |||
| Normalized Diluted EPS | 0.00% | -90.33% | |||
| Average Basic Shares Outstanding | 0.00% | -1.21% | |||
| Average Diluted Shares Outstanding | 0.00% | -1.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.00% | -- | |||